(FIND-QCA-PATH :TARGET "<TERM id=\"V33791\" dbid=\"HGNC:11998|NCIT:C52271|NCIT:C17387\"><features></features><type>ONT::GENE-PROTEIN</type><name>TP-53</name><drum-terms><drum-term dbid=\"HGNC:11998\" match-score=\"0.99587\" name=\"tumor protein p53\" /><drum-term dbid=\"NCIT:C52271\" match-score=\"0.99587\" name=\"TP53\" /><drum-term dbid=\"NCIT:C17387\" match-score=\"0.82444\" name=\"tumor protein-p53\" /></drum-terms></TERM>" :SOURCE "<TERM id=\"V33776\" dbid=\"HGNC:11364|NCIT:C52153|NCIT:C28664\"><features></features><type>ONT::GENE-PROTEIN</type><name>STAT-3</name><drum-terms><drum-term dbid=\"HGNC:11364\" match-score=\"0.99587\" name=\"signal transducer and activator of transcription 3\" /><drum-term dbid=\"NCIT:C52153\" match-score=\"0.99587\" name=\"STAT3\" /><drum-term dbid=\"NCIT:C28664\" match-score=\"0.82444\" name=\"signal transducer and activator of transcription-3\" /></drum-terms></TERM>")
(SUCCESS)
(FIND-QCA-PATH :TARGET "<TERM id=\"V35286\" dbid=\"HGNC:6877|NCIT:C52875|NCIT:C17408\"><features></features><type>ONT::GENE-PROTEIN</type><name>MAPK-3</name><drum-terms><drum-term dbid=\"HGNC:6877\" match-score=\"1.0\" name=\"mitogen-activated protein kinase 3\" /><drum-term dbid=\"NCIT:C52875\" match-score=\"1.0\" name=\"MAPK3\" /><drum-term dbid=\"NCIT:C17408\" match-score=\"0.82857\" name=\"MAP-kinase-3\" /></drum-terms></TERM>" :SOURCE "<TERM id=\"V35269\" dbid=\"HGNC:6407|NCIT:C16766|NCIT:C17383|UP:Q9YH38|UP:Q5EFX7|UP:P79800|UP:O42277|UP:Q05147\"><features></features><type>ONT::GENE-PROTEIN</type><name>KRAS</name><drum-terms><drum-term dbid=\"HGNC:6407\" match-score=\"1.0\" name=\"KRAS proto-oncogene, GTPase\" /><drum-term dbid=\"NCIT:C16766\" match-score=\"0.82857\" name=\"oncogene K-ras\" /><drum-term dbid=\"NCIT:C17383\" match-score=\"0.82857\" name=\"p21 K-ras protein\" /><drum-term dbid=\"UP:Q9YH38\" match-score=\"0.65534\" name=\"GTPase KRas\" /><drum-term dbid=\"UP:Q5EFX7\" match-score=\"0.65534\" name=\"GTPase KRas\" /><drum-term dbid=\"UP:P79800\" match-score=\"0.65534\" name=\"GTPase KRas\" /><drum-term dbid=\"UP:O42277\" match-score=\"0.65534\" name=\"GTPase KRas\" /><drum-term dbid=\"UP:Q05147\" match-score=\"0.65534\" name=\"GTPase KRas\" /></drum-terms></TERM>")
(SUCCESS)
(FIND-QCA-PATH :SOURCE "<TERM id=\"V33884\" dbid=\"NCIT:C52538|HGNC:3113|UP:Q90977|UP:Q01094|UP:Q61501|UP:O09139|NCIT:C17546|NCIT:C106338\"><features></features><type>ONT::GENE-PROTEIN</type><name>E-2-F-1</name><drum-terms><drum-term dbid=\"NCIT:C52538\" match-score=\"0.99587\" name=\"E2F1\" /><drum-term dbid=\"HGNC:3113\" match-score=\"0.99587\" name=\"E2F transcription factor 1\" /><drum-term dbid=\"UP:Q90977\" match-score=\"0.99581\" name=\"Transcription factor E2F1\" /><drum-term dbid=\"UP:Q01094\" match-score=\"0.99581\" name=\"Transcription factor E2F1\" /><drum-term dbid=\"UP:Q61501\" match-score=\"0.99581\" name=\"Transcription factor E2F1\" /><drum-term dbid=\"UP:O09139\" match-score=\"0.99581\" name=\"Transcription factor E2F1\" /><drum-term dbid=\"NCIT:C17546\" match-score=\"0.82444\" name=\"E2F transcription factor-1\" /><drum-term dbid=\"NCIT:C106338\" match-score=\"0.82438\" name=\"UBE2L3\" /></drum-terms></TERM>" :TARGET "<TERM id=\"V33893\" dbid=\"HGNC:9588|NCIT:C52906|NCIT:C18181|GO:0051800\"><features></features><type>ONT::GENE-PROTEIN</type><name>PTEN</name><drum-terms><drum-term dbid=\"HGNC:9588\" match-score=\"0.99587\" name=\"phosphatase and tensin homolog\" /><drum-term dbid=\"NCIT:C52906\" match-score=\"0.99587\" name=\"PTEN\" /><drum-term dbid=\"NCIT:C18181\" match-score=\"0.82444\" name=\"PTEN tyrosine phosphatase\" /><drum-term dbid=\"GO:0051800\" match-score=\"0.48158\" name=\"phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity\" /></drum-terms></TERM>")
(SUCCESS :paths ("[{\"type\": \"Complex\", \"id\": \"ad158b68-fc54-4ea1-837f-eef66b73b727\", \"members\": [{\"db_refs\": {\"UP\": \"Q01094\", \"HGNC\": \"3113\"}, \"name\": \"E2F1\"}, {\"db_refs\": {\"PFH\": \"TFDP Family\", \"TEXT\": \"TFDP Family\", \"BE\": \"TFDP\"}, \"name\": \"TFDP\"}, {\"db_refs\": {\"UP\": \"P06400\", \"HGNC\": \"9884\"}, \"name\": \"RB1\"}], \"evidence\": [{\"source_id\": \"http://www.openbel.org/bel/p_HGNC_RB1_pmod_P_Decreases_complex_p_HGNC_E2F1_p_PFH_TFDP_Family_p_HGNC_RB1\", \"text\": \"<E2> Unphosphorylated (or hypophosphorylated) pRb can bind to DP complexes of E2F1?3 and to a lesser degree E2F4. Binding of pRb family members is mediated by a short, highly conserved domain in the C-terminal region of E2F proteins. The E2F-binding site is in the C-terminal region of pRb.\", \"pmid\": \"10436023\", \"source_api\": \"bel\"}]}, {\"type\": \"Complex\", \"id\": \"229fa14a-831c-4c38-83ce-a6c86b7a91b9\", \"members\": [{\"db_refs\": {\"UP\": \"P06400\", \"HGNC\": \"9884\"}, \"name\": \"RB1\"}, {\"db_refs\": {\"UP\": \"P00519\", \"HGNC\": \"76\"}, \"name\": \"ABL1\"}], \"evidence\": [{\"source_id\": \"http://www.openbel.org/bel/complex_p_HGNC_ABL1_p_HGNC_RB1_Decreases_kin_p_HGNC_ABL1\", \"text\": \"<A8> c-Abl tyrosine kinase activity is blocked by pRb, which binds to the c-Abl kinase domain (Welch and Wang, 1995).\", \"pmid\": \"10436023\", \"source_api\": \"bel\"}, {\"source_id\": \"http://www.openbel.org/bel/p_HGNC_RB1_pmod_P_Decreases_complex_p_HGNC_ABL1_p_HGNC_RB1\", \"text\": \"<A9> Phosphorylation of pRb disrupts the c-Abl:pRb complex and releases active c-Abl (Welch and Wang, 1995).\", \"pmid\": \"10436023\", \"source_api\": \"bel\"}]}, {\"residue\": \"Y\", \"sub\": {\"db_refs\": {\"UP\": \"P00533\", \"HGNC\": \"3236\"}, \"name\": \"EGFR\"}, \"supported_by\": [\"4e4ef785-bd6f-489e-acd5-ce7315cf5ed3\"], \"evidence\": [{\"source_id\": \"http://www.openbel.org/bel/kin_p_HGNC_ABL1_DirectlyIncreases_p_HGNC_EGFR_pmod_P_Y_1173\", \"text\": \"Moreover, we show that activated Abl phosphorylates the EGFR primarily on tyrosine 1173, and that mutation of this site to phenylalanine restores ligand-dependent endocytosis of the EGFR in the presence of activated Abl.\", \"pmid\": \"16943190\", \"source_api\": \"bel\"}], \"position\": \"1197\", \"enz\": {\"db_refs\": {\"UP\": \"P00519\", \"HGNC\": \"76\"}, \"name\": \"ABL1\"}, \"type\": \"Phosphorylation\", \"id\": \"6d461fd9-ddeb-490b-b46e-860bb5b5bcdb\"}, {\"sub\": {\"db_refs\": {\"TEXT\": \"ERK1/2\", \"BE\": \"ERK\"}, \"name\": \"ERK\"}, \"supported_by\": [\"a215914a-148d-4c88-8ad2-0c6e16084b99\", \"7c879945-0f45-45ab-9cb7-8066cf1c3201\"], \"evidence\": [{\"text\": \"In such cells, inhibition of EGFR activity can abrogate phosphorylation of ERK1/2 upon stimulation with EGF, suggesting that the EGFR/RAS/RAF/MEK/ERK pathway can be functional in SCLCcells.\", \"pmid\": \"27133774\", \"source_api\": \"reach\", \"annotations\": {\"found_by\": \"Phosphorylation_syntax_1a_noun\"}, \"epistemics\": {\"hypothesis\": true, \"section_type\": null, \"direct\": false}}, {\"text\": \"Addition of rhAREG induced ERK phosphorylation in the presence or absence of Tet, whereas the EGFR tyrosine kinase inhibitor PD158780 and the MEKinhibitor U0126 each abrogated autocrine ERK phosphorylation in both lines.\", \"pmid\": \"26802239\", \"source_api\": \"reach\", \"annotations\": {\"found_by\": \"Phosphorylation_syntax_4_noun\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}, {\"text\": \"The specificity of EDNRB mediated activation of EGFR was shown by the ability of the EGFR-kinase inhibitor AG1478 and EGFR siRNAs to reduce phosphorylation of both the EGFR and ERK1/2.\", \"pmid\": \"27930693\", \"source_api\": \"reach\", \"annotations\": {\"found_by\": \"Phosphorylation_syntax_1a_noun\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}, {\"text\": \"OVA stimulated Erk1/2 phosphorylation was blocked by inhibitors of EGFR, Src, MEK, and Erk1/2 but not affected by an inhibitor of Rho kinase.\", \"pmid\": \"26521832\", \"source_api\": \"reach\", \"annotations\": {\"found_by\": \"Phosphorylation_syntax_4_noun\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}, {\"text\": \"The epidermal growth factor receptor (EGFR) inhibitor erlotinib blocked ERK1/2 phosphorylation and increased PGC-1alpha gene expression similar to treatment with trametinib, linking EGFR activation and FOXO3a/1 inactivation to the down-regulation of PGC-1alpha and MB through ERK1/2.\", \"pmid\": \"27875304\", \"source_api\": \"reach\", \"annotations\": {\"found_by\": \"Phosphorylation_syntax_4_noun\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}, {\"text\": \"Cell proliferation and ERK1/2 phosphorylation in response to prolonged stimulation with AVP were abolished by inhibition of G protein coupled receptor kinase 2 (GRK2) and epidermal growth factor receptor (EGFR) using specific inhibitors or small hairpin RNA knock-down.\", \"pmid\": \"27773680\", \"source_api\": \"reach\", \"annotations\": {\"found_by\": \"Phosphorylation_syntax_4_noun\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}, {\"text\": \"Gefitinib, a selective EGFR tyrosine kinase inhibitor, down-regulated the phosphorylation of EGFR, AKT and Erk while it exerted little effect on total protein of EGFR, AKT and Erk in MB49 (XREF_FIG).\", \"pmid\": \"27334428\", \"source_api\": \"reach\", \"annotations\": {\"found_by\": \"Phosphorylation_syntax_1a_noun\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}, {\"text\": \"The combination of RET inhibitors and gefitinib inhibited phosphorylation of AKT and ERK by RET and EGFR even in the presence of EGF (XREF_FIG, lanes 4 and 7, rows 5-8).\", \"pmid\": \"27873490\", \"source_api\": \"reach\", \"annotations\": {\"found_by\": \"Phosphorylation_syntax_1a_noun\"}, \"epistemics\": {\"section_type\": null, \"direct\": true}}, {\"text\": \"Furthermore, the combination of PA-MSHA plus Gefitinib resulted in caspase-3 and caspase-9 cleavage and increased inhibition of EGFR dependent activation of AKT and ERK phosphorylation.\", \"pmid\": \"27283902\", \"source_api\": \"reach\", \"annotations\": {\"found_by\": \"Phosphorylation_syntax_4_noun\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}, {\"text\": \"We have demonstrated that ACh could act though M3R to activate EGFR pathway, while knockdown M3R or inhibiting EGFR could reverse the cell proliferation and phosphorylation of ERK and AKT induced by ACh stimulation in gastric cancer.\", \"pmid\": \"28102288\", \"source_api\": \"reach\", \"annotations\": {\"found_by\": \"Phosphorylation_syntax_4_noun\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"enz\": {\"db_refs\": {\"TEXT\": \"EGFR\", \"UP\": \"P00533\", \"HGNC\": \"3236\"}, \"name\": \"EGFR\"}, \"type\": \"Phosphorylation\", \"id\": \"e48540db-00b1-4406-a47a-96853328ff32\"}, {\"enz\": {\"db_refs\": {\"TEXT\": \"ERK\", \"BE\": \"ERK\"}, \"name\": \"ERK\"}, \"evidence\": [{\"text\": \"In agreement with our study, ERK has been previously reported to inactivate LKB1 and AMPK signaling in melanoma cells by phosphorylating LKB1 and compromising the ability of LKB1 to bind and activate AMPK activation [XREF_BIBR].\", \"pmid\": \"28033353\", \"source_api\": \"reach\", \"annotations\": {\"found_by\": \"Phosphorylation_syntax_1a_verb\"}, \"epistemics\": {\"section_type\": null, \"direct\": false}}], \"type\": \"Phosphorylation\", \"sub\": {\"db_refs\": {\"TEXT\": \"LKB1\", \"UP\": \"Q15831\", \"HGNC\": \"11389\"}, \"name\": \"STK11\"}, \"id\": \"91128f4c-9b17-49a0-9360-130f13e911eb\"}, {\"residue\": \"S\", \"sub\": {\"db_refs\": {\"UP\": \"P60484\", \"HGNC\": \"9588\"}, \"name\": \"PTEN\"}, \"supported_by\": [\"44b94517-45df-408d-8211-a40dab6928d6\"], \"evidence\": [{\"source_id\": \"http://pathwaycommons.org/pc2/Catalysis_210aaca8843ea7e05b4ffc1e13387eb2\", \"source_api\": \"biopax\"}], \"position\": \"380\", \"enz\": {\"db_refs\": {\"UP\": \"Q15831\", \"HGNC\": \"11389\"}, \"name\": \"STK11\"}, \"type\": \"Phosphorylation\", \"id\": \"0bb2913c-57e7-4e45-9262-9b1252ac2889\"}]"))
